Atrial Fibrillation Market Size, Market Share, Application Analysis, Regional Outlook, Growth, Trends, Competitive Scenario And Forecasts, 2012 To 2020

Table of Contents

Chapter 1. Executive Summary
1.1. Atrial fibrillation - Industry Summary & Critical Success Factors (CSFs)

Chapter 2. Atrial fibrillation Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Atrial fibrillation Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Atrial fibrillation - Company Market Share Analysis, 2013
2.7. Atrial fibrillation Market PESTEL Analysis, 2013

Chapter 3. Atrial fibrillation Procedures Outlook
3.1. Pharmacological Drugs
3.1.1. Global Pharmacological Drugs for Atrial Fibrillation demand, 2012 - 2020 (USD Million)
3.1.1.1. Global Pharmacological Drugs Market demand, 2012 - 2020 (USD Million)
3.1.1.2. Anti-arrhythmic Drugs Market demand, 2012 - 2020 (USD Million)
3.1.1.3. Anti-coagulant Drugs Market demand, 2012 - 2020 (USD Million)
3.2. Non-Pharmacological Procedures
3.2.1. Global Catheter Ablation Procedures demand, 2012 - 2020 (USD Million)
3.2.1.1. Radiofrequency Catheter Ablation demand, 2012 - 2020 (USD Million)
3.2.1.2. HIFU Catheter Ablation demand, 2012 - 2020 (USD Million)
3.2.1.3. Catheter Cryoablation demand, 2012 - 2020 (USD Million)
3.2.1.4. Microwave Catheter Ablation demand, 2012 - 2020 (USD Million)
3.2.1.5. Laser Catheter Ablation demand, 2012 - 2020 (USD Million)
3.2.2. Global Maze Surgery demand, 2012 - 2020 (USD Million)
3.2.3. Global Electric Cardioversion demand, 2012 - 2020 (USD Million)

Chapter 4. Atrial fibrillation Regional Outlook
4.1. North America
4.1.1. North America atrial fibrillation market revenue by procedure, 2012 - 2020 (USD Million)
4.2. Europe
4.2.1. Europe atrial fibrillation market revenue by procedure, 2012 - 2020 (USD Million)
4.3. Asia Pacific
4.3.1. Asia Pacific atrial fibrillation market revenue by procedure, 2012 - 2020 (USD Million)
4.4. RoW
4.4.1. RoW atrial fibrillation market revenue by procedure, 2012 - 2020 (USD Million)

Chapter 5 Company Profiles
5.1 AtriCure Inc.
5.1.1 Company overview
5.1.2 Financial Performance
5.1.3 Product Benchmarking
5.1.4 Strategic Initiatives
5.2 Biosense Webster Inc.
5.2.1 Company overview
5.2.2 Product Benchmarking
5.2.3 Strategic Initiatives
5.3 Boehringer Ingelheim GmbH
5.3.1 Company overview
5.3.2 Financial Performance
5.3.3 Product Benchmarking
5.3.4 Strategic Initiatives
5.4 Boston Scientific Corporation
5.4.1 Company overview
5.4.2 Financial Performance
5.4.3 Product Benchmarking
5.4.4 Strategic Initiatives
5.5 Bristol- Myers Squibb Corporation
5.5.1 Company overview
5.5.2 Financial Performance
5.5.3 Product Benchmarking
5.5.4 Strategic Initiatives
5.6 Cardio Focus Inc.
5.6.1 Company overview
5.6.2 Financial Performance
5.6.3 Product Benchmarking
5.6.4 Strategic Initiatives
5.7 Endoscopic Technologies Inc.
5.7.1 Company overview
5.7.2 Financial Performance
5.7.3 Product Benchmarking
5.7.4 Strategic Initiatives
5.8 Sanofi Aventis
5.8.1 Company overview
5.8.2 Financial Performance
5.8.3 Product Benchmarking
5.8.4 Strategic Initiatives
5.9 St. Jude Medical Inc.
5.9.1 Company overview
5.9.2 Financial Performance
5.9.3 Product Benchmarking
5.9.4 Strategic Initiatives
5.10 Johnsons & Johnson Ltd
5.10.1 Company overview
5.10.2 Financial Performance
5.10.3 Product Benchmarking
5.10.4 Strategic Initiatives

Chapter 6. Methodology and Scope
6.1. Research Methodology
6.2. Research Scope & Assumption
6.3. List of Data Sources